Analyst rating updates for Krystal Biotech, including a buy rating from TD Cowen and a consensus rating from MarketBeat.
3 reports, 2 independent
Updated Fri 00:00
No new developments lately
- Reports
- 3
- Developments
- 2
- Repetition
- 33%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Analyst rating updates for Krystal Biotech, including a buy rating from TD Cowen and a consensus rating from MarketBeat.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.MarketBeat expanded its analyst ratings comparison to include Applied Therapeutics.1 source
TD Cowen raised its price target and gave a buy rating for Krystal Biotech, while Jefferies reiterated buy status.1 source
Keep exploring
The entities involved
-
Krystal Biotech, Inc.
biotechnology company
Nothing else this week.
-
MarketBeat
American personal finance blog
-
TD Cowen
American investment bank
-
Jefferies Financial Group
American financial services company
Related events
- MarketBeat provided consensus rating data on Navios Maritime Partners LP, while Jefferies Financial Group assumed coverage and issued a buy rating.
- MarketBeat provided stock rating data as Berenberg Bank cut its price target and Jefferies issued a buy rating report for LondonMetric Property Plc.
- Global Mofy AI Limited was listed on the stock exchange and received a consensus rating from MarketBeat.
- Texas Roadhouse received multiple analyst rating and price target updates from Jefferies and TD Cowen, alongside stock listing information.
- TD Cowen and Needham & Company boosted the price target and gave a 'buy' rating for Ultra Clean.